Cargando…
Assessment of Price and Clinical Benefit of Cancer Drugs in Canada, 2011-2020
This cohort study examines the association between approval characteristics, clinical benefit, and prices of cancer drugs recommended for reimbursement by the Canadian Agency for Drug and Technology in Health.
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Medical Association
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890281/ https://www.ncbi.nlm.nih.gov/pubmed/36719684 http://dx.doi.org/10.1001/jamanetworkopen.2022.53438 |
| Sumario: | This cohort study examines the association between approval characteristics, clinical benefit, and prices of cancer drugs recommended for reimbursement by the Canadian Agency for Drug and Technology in Health. |
|---|